Progress seen on five fronts for substantially improving treatment of epidermolysis bullosaJuly 27, 2023PediatricsRare DiseasesDermatology
Case report describes pediatric RIME triggered by norovirusJuly 20, 2023PediatricsInfectious DiseasesRare DiseasesDermatology
In new era of gene therapy, PCPs are ‘boots on the ground’July 19, 2023Rare DiseasesPediatricsEndocrinology
Camp Discovery: A place for children to be comfortable in their own skinJuly 14, 2023PediatricsRare DiseasesDermatology
New guidelines for MTX use in pediatric inflammatory skin disease unveiledJuly 5, 2023PediatricsRare DiseasesDermatology
FDA approves ritlecitinib for ages 12 and up for alopecia areataJune 26, 2023PediatricsRare DiseasesDermatology
Scientists discover variants, therapy for disabling pansclerotic morpheaJune 2, 2023Rare DiseasesDermatologyRheumatologyMixed Topics
FDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023PediatricsRare DiseasesDermatologyGastroenterologyRheumatology
FDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023PediatricsDermatologyGastroenterologyRheumatologyRare Diseases
